|Bid||37.84 x 1300|
|Ask||38.00 x 1800|
|Day's Range||37.48 - 38.02|
|52 Week Range||27.88 - 40.97|
|Beta (5Y Monthly)||0.66|
|PE Ratio (TTM)||15.01|
|Earnings Date||Oct 27, 2020|
|Forward Dividend & Yield||1.52 (4.01%)|
|Ex-Dividend Date||Nov 05, 2020|
|1y Target Est||41.33|
AstraZeneca posted positive interim Phase 2 testing data on its Covid-19 vaccine candidate in older adults, while Moderna inked a supply contract with Qatar, as MRNA stock, AZN stock rose.
An analyst expressed concern that no news so far from a late-stage study of coronavirus vaccine BNT162b2 could be bad news.
During Friday's Mad Money program Jim Cramer laid out his game plan for the stock market this week. The highlights on Tuesday include Pfizer and Merck , along with Caterpillar , Microsoft and Stanley Black & Decker . Cramer was anxious to hear an update on Pfizer's Covid vaccine and I am anxious to see how prices act if they decline a little bit further.